June 2011 Briefing - Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for June 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

New Tool Validated for Vision-Related Quality of Life

TUESDAY, June 28 (HealthDay News) -- The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) instrument is a validated and reliable tool which may be useful for determining vision-related quality of life (VRQOL) in visually impaired children with juvenile idiopathic arthritis-associated uveitis (JIA-U), according to a study published online June 15 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Liver Fibrosis Tied to Hep C-Related Vasculitis Prognosis

FRIDAY, June 24 (HealthDay News) -- In patients with hepatitis C virus (HCV)-related systemic vasculitis, severity of liver fibrosis and vasculitis at baseline are associated with disease prognosis, according to a study published in the June issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Anti-TNF Doesn't Increase Complication Risk in Early RA

TUESDAY, June 21 (HealthDay News) -- Patients with early rheumatoid arthritis (RA) who are treated with anti-tumor necrosis factor (anti-TNF) therapy do not have an increased risk of serious infections and malignancies compared to those treated with methotrexate (MTX), according to a meta-analysis published in the June issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Antirheumatic Drugs Linked to Lower Diabetes Risk

TUESDAY, June 21 (HealthDay News) -- Treatment of rheumatoid arthritis (RA) or psoriasis with biologic disease-modifying antirheumatic drugs (DMARDs), such as tumor necrosis factor (TNF) inhibitors, methotrexate, and hydroxychloroquine, may reduce the risk of newly recorded diabetes mellitus (DM), according to a study published in the June 22/29 issue of the Journal of the American Medical Association.

Abstract
Full Text
Editorial (subscription or payment may be required)

Hospital Surgery Volume Tied to Arthroplasty Complications

FRIDAY, June 17 (HealthDay News) -- For patients undergoing primary elective total hip arthroplasty (THA) in hospitals with a low annual volume of surgeries, the risk of venous thromboembolism and one-year mortality is significantly higher than in high-volume hospitals, and for patients aged 65 or older undergoing total knee arthroplasty (TKA) at a low-volume hospital, there is an associated risk of increased one-year mortality, according to a study published online June 7 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Unequal Care Access for Children With Public Insurance

THURSDAY, June 16 (HealthDay News) -- Access to outpatient care is restricted for children with public insurance compared to those with private insurance, according to a study published in the June 16 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Life Expectancy in U.S. Counties Below Many Nations

WEDNESDAY, June 15 (HealthDay News) -- Most counties within the United States fall behind the international frontier with the best life expectancies in the world, according to a study published online June 15 in Population Health Metrics.

Abstract
Full Text

Similar Number for Outpatient, Inpatient Malpractice Claims

TUESDAY, June 14 (HealthDay News) -- The number of paid malpractice claims is similar in both inpatient and outpatient settings, according to a study published in the June 15 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

First Ceramic-on-Metal Hip Replacement Approved

TUESDAY, June 14 (HealthDay News) -- The first ceramic-on-metal total hip replacement system has been approved by the U.S. Food and Drug Administration.

hip replacement

Rheumatoid Arthritis May Delay Time to Pregnancy

TUESDAY, June 14 (HealthDay News) -- Women with rheumatoid arthritis (RA) prior to conceiving may have a longer time to pregnancy (TTP), according to a study published in the June issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Multidisciplinary Therapy May Improve Systemic Sclerosis

MONDAY, June 13 (HealthDay News) -- For patients with systemic sclerosis (SSc), a multidisciplinary program offers better improvement of grip strength, maximal mouth opening (MMO), six-minute walk distance (6MWD), and SSc Health Assessment Questionnaire (HAQ) score than regular outpatient care, according to a study published in the June issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Modular Prostheses Provide Stable Elbow Reconstruction

MONDAY, June 13 (HealthDay News) -- Elbow reconstruction with modular prostheses of the distal end of the humerus offers stable reconstruction after tumor resection, but it is less successful for revision surgery in patients without a tumor, according to a study published in the June 1 issue of The Journal of Bone & Joint Surgery.

Abstract
Full Text (subscription or payment may be required)

Splints May Reduce Hand Pain in Hand Osteoarthritis

FRIDAY, June 10 (HealthDay News) -- Use of splints may reduce hand pain in patients with hand osteoarthritis, according to a review published online May 31 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Fibromyalgia Syndrome May Be Linked to Abuse

THURSDAY, June 9 (HealthDay News) -- Significant correlations may exist between fibromyalgia syndrome (FMS) and self-reported sexual and physical abuse in childhood and/or adulthood, according to a meta-analysis published in the June issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

NSAID Use Linked to Increased Venous Thromboembolism Risk

WEDNESDAY, June 8 (HealthDay News) -- The use of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase-2-selective inhibitors (COX2Is) is associated with an increased risk of venous thromboembolism (VTE), according to a study published online May 18 in the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

Youth Bear Large Burden of Global Death, Disease

TUESDAY, June 7 (HealthDay News) -- Youths between the ages of 10 and 24 years carry 15.5 percent of the global burden of disability-adjusted life-years (DALYs), according to a study published online June 7 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Low Success Rate for Universal Wrist Prosthesis in RA

FRIDAY, June 3 (HealthDay News) -- Wrist arthroplasty with Universal wrist prosthesis has a high failure rate in patients with rheumatoid arthritis (RA), mainly due to carpal component loosening, according to a study published in the May 18 issue of The Journal of Bone & Joint Surgery.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com